PD
ACAD icon

Point72 (DIFC)’s Acadia Pharmaceuticals ACAD Stock Holding History

Point72 (DIFC)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,764
Closed -$211K – 1124
2025
Q2 		$211K Buy
9,764
+5,539
+131% +$103K 0.02% 773
2025
Q1 		$70.2K Sell
4,225
-39,370
-90% -$715K 0.01% 1145
2024
Q4 		$800K Buy
+43,595
New +$704K 0.07% 523
2024
Q3 		– Sell
-1,232
Closed -$20K – 1400
2024
Q2 		$20K Sell
1,232
-76,131
-98% -$1.23M ﹤0.01% 1233
2024
Q1 		$1.43M Buy
+77,363
New +$1.92M 0.11% 476

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return